SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (287)2/13/2003 11:29:00 AM
From: Jibacoa  Respond to of 3722
 
BDAL Is up only 7.11% and volume of 13K is still 1/3 of its daily average.<g>

Earnings report are scheduled for Thursday next week. The insiders still hold about 85% of the stock and institutions more than 135% of the float, in spite of some reported selling lately.<g>It has around $0.90 in cash/share and its ttm loss is only $0.01

The float is less than 9M and there is a short ratio of more than 19% of the float (about 36x its daily trading average)

The stock is trading ahead of yesterday's H and seems ready to test resistance at the 4.50 level.

The stock needs to close above its Jan.13 H of 5.10 before it can test its Dec.20 H at 5.73 and its Nov.4 H at 6.10 but in view of the previously mentioned fundies data. it seems worth of keeping it under a close watch.<g>

I would start buying some on a close above 4.50 and will make a more substantial commitment if it can close above its September 6 H of 6.39 <g>

siliconinvestor.com

siliconinvestor.com

Bernard